Size Matters: Molecular Weight Specificity of Hyaluronan Effects in Cell Biology

International Journal of Cell Biology

Volumn 2015, Issue , 2015, Pages

  Cyphert, Jaime M ^a   Trempus, Carol S ^a   Garantziotis, Stavros ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; HYALURONIC ACID; HYALURONIDASE;

APOPTOSIS; CELL ADHESION; CELL COMMUNICATION; CELL DIVISION; CELL FUNCTION; CELL MEMBRANE; CELL MIGRATION; CELL SPECIFICITY; CELL SURFACE; CELL SURVIVAL; CHEMICAL STRUCTURE; CYTOLOGY; ENZYMATIC DEGRADATION; EXTRACELLULAR MATRIX; HUMAN; INTRACELLULAR SIGNALING; MOLECULAR WEIGHT; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW;

EID: 84937228189     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2015/563818     Document Type: Review

References (93)

1. J. Lesley, V. C. Hascall, M. Tammi, and R. Hyman, "Hyaluronan binding by cell surface CD44," Journal of Biological Chemistry, vol. 275, no. 35, pp. 26967-26975, 2000.
2. D. Jiang, J. Liang, and P. W. Noble, "Hyaluronan in tissue injury and repair," Annual Review of Cell and Developmental Biology, vol. 23, pp. 435-461, 2007.
3. T. C. Laurent and J. R. E. Fraser, "Hyaluronan," The FASEB Journal, vol. 6, no. 7, pp. 2397-2404, 1992.
4. K. T. Dicker, L. A. Gurski, S. Pradhan-Bhatt, R. L. Witt, M. C. Farach-Carson, and X. Jia, "Hyaluronan: a simple polysaccharide with diverse biological functions," Acta Biomaterialia, vol. 10, no. 4, pp. 1558-1570, 2014.
5. A. P. Spicer and J. A. McDonald, "Characterization and molecular evolution of a vertebrate hyaluronan synthase gene family," The Journal of Biological Chemistry, vol. 273, no. 4, pp. 1923-1932, 1998.
6. P. Prehm, "Hyaluronate is synthesized at plasma membranes," Biochemical Journal, vol. 220, no. 2, pp. 597-600, 1984.
7. P. Prehm, "Identification and regulation of the eukaryotic hyaluronate synthase," Ciba Foundation Symposium, vol. 143, pp. 21-40, 1989.
8. N. Itano, T. Sawai, M. Yoshida et al., "Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties," Journal of Biological Chemistry, vol. 274, no. 35, pp. 25085-25092, 1999.
9. J. Y. L. Tien and A. P. Spicer, "Three vertebrate hyaluronan synthases are expressed during mouse development in distinct spatial and temporal patterns," Developmental Dynamics, vol. 233, no. 1, pp. 130-141, 2005.
10. T. D. Camenisch, A. P. Spicer, T. Brehm-Gibson et al., "Disruption of hyaluronan synthase-2 abrogates normal cardiac morphogenesis and hyaluronan-mediated transformation of epithelium to mesenchyme," Journal of Clinical Investigation, vol. 106, no. 3, pp. 349-360, 2000.
11. D. Jiang, J. Liang, and P. W. Noble, "Hyaluronan as an immune regulator in human diseases," Physiological Reviews, vol. 91, no. 1, pp. 221-264, 2011.
12. K. M. Stuhlmeier and C. Pollaschek, "Differential effect of transforming growth factor β (TGF-β) on the genes encoding hyaluronan synthases and utilization of the p38MAPK pathway in TGF-β-induced hyaluronan synthase 1 activation," Journal of Biological Chemistry, vol. 279, no. 10, pp. 8753-8760, 2004.
13. S. Adamia, P. M. Pilarski, A. R. Belch, and L. M. Pilarski, "Aberrant splicing, hyaluronan synthases and intracellular hyaluronan as drivers of oncogenesis and potential drug targets," Current Cancer Drug Targets, vol. 13, no. 4, pp. 347-361, 2013.
14. Y. Li, D. Jiang, J. Liang et al., "Severe lung fibrosis requires an invasive fibroblast phenotype regulated by hyaluronan and CD44," Journal of Experimental Medicine, vol. 208, no. 7, pp. 1459-1471, 2011.
15. D. Jiang, J. Liang, J. Fan et al., "Regulation of lung injury and repair by Toll-like receptors and hyaluronan," Nature Medicine, vol. 11, no. 11, pp. 1173-1179, 2005.
16. A. B. Csoka, G. I. Frost, and R. Stern, "The six hyaluronidaselike genes in the human and mouse genomes," Matrix Biology, vol. 20, no. 8, pp. 499-508, 2001.
17. R. Stern and M. J. Jedrzejas, "Hyaluronidases: their genomics, structures, and mechanisms of action," Chemical Reviews, vol. 106, no. 3, pp. 818-839, 2006.
18. R. Stern, "Hyaluronan catabolism: a new metabolic pathway," EuropeanJournal of Cell Biology, vol. 83, no. 7, pp. 317-325, 2004.
19. K. Meyer, "Chemical structure of hyaluronic acid," Federation Proceedings, vol. 17, no. 4, pp. 1075-1077, 1958.
20. M. Erickson and R. Stern, "Chain gangs: new aspects of hyaluronan metabolism," Biochemistry Research International, vol. 2012, Article ID 893947, 9 pages, 2012.
21. V. B. Lokeshwar and M. G. Selzer, "Hyalurondiase: both a tumor promoter and suppressor," Seminars in Cancer Biology, vol. 18, no. 4, pp. 281-287, 2008.
22. B. Triggs-Raine, T. J. Salo, H. Zhang, B. A. Wicklow, and M. R. Natowicz, "Mutations in HYAL1, a member of a tand emly distributed multigene family encoding disparate hyaluronidase activities, cause a newly described lysosomal disorder, mucopolysaccharidosis IX," Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 11, pp. 6296-6300, 1999.
23. T. Kaneiwa, S. Mizumoto, K. Sugahara, and S. Yamada, "Identification of human hyaluronidase-4 as a novel chondroitin sulfate hydrolase that preferentially cleaves the galactosaminidic linkage in the trisulfated tetrasaccharide sequence," Glycobiology, vol. 20, no. 3, pp. 300-309, 2009.
24. L. Y. W. Bourguignon, P. A. Singleton, F. Diedrich, R. Stern, and E. Gilad, "CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion," Journal of Biological Chemistry, vol. 279, no. 26, pp. 26991-27007, 2004.
25. M. R. Natowicz, M. P. Short, Y. Wang et al., "Clinical and biochemical manifestations of hyaluronidase deficiency," The New England Journal ofMedicine, vol. 335, no. 14, pp. 1029-1033, 1996.
26. L. Jadin, X. Wu, H. Ding et al., "Skeletal and hematological anomalies in HYAL2-deficient mice: a second type of mucopolysaccharidosis IX?" The FASEB Journal, vol. 22, no. 12, pp. 4316-4326, 2008.
27. B. Chowdhury, R. Hemming, S. Hombach-Klonisch, B. Flamion, and B. Triggs-Raine, "Murine hyaluronidase 2 deficiency results in extracellular hyaluronan accumulation and severe cardiopulmonary dysfunction," The Journal of Biological Chemistry, vol. 288, no. 1, pp. 520-528, 2013.
28. J. Muto, Y. Morioka, K. Yamasaki et al., "Hyaluronan digestion controls DC migration from the skin," The Journal of Clinical Investigation, vol. 124, no. 3, pp. 1309-1319, 2014.
29. R. Stern, G. Kogan, M. J. Jedrzejas, and L. Šoltés, "The many ways to cleave hyaluronan," Biotechnology Advances, vol. 25, no. 6, pp. 537-557, 2007.
30. M. Oettl, J. Hoechstetter, I. Asen, G. Bernhardt, and A. Buschauer, "Comparative characterization of bovine testicular hyaluronidase and a hyaluronate lyase from Streptococcus agalactiae in pharmaceutical preparations," European Journal of Pharmaceutical Sciences, vol. 18, no. 3-4, pp. 267-277, 2003.
31. L. Šoltés, R. Mendichi, G. Kogan, J. Schiller, M. Stankovská, and J. Arnhold, "Degradative action of reactive oxygen species on hyaluronan," Biomacromolecules, vol. 7, no. 3, pp. 659-668, 2006.
32. M. E. Monzon, N. Fregien, N. Schmid et al., "Reactive oxygen species and hyaluronidase 2 regulate airway epithelial hyaluronan fragmentation," The Journal of Biological Chemistry, vol. 285, no. 34, pp. 26126-26134, 2010.
33. F. Gao, J. R. Koenitzer, J. M. Tobolewski et al., "Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan," Journal of Biological Chemistry, vol. 283, no. 10, pp. 6058-6066, 2008.
34. G. M. Campo, A. Avenoso, A. DAscola et al., "Inhibition of hyaluronan synthesis reduced inflammatory response in mouse synovial fibroblasts subjected to collagen-induced arthritis," Archives of Biochemistry and Biophysics, vol. 518, no. 1, pp. 42-52, 2012.
35. G. M. Campo, A. Avenoso, A. DAscola et al., "The SOD mimic MnTM-2-PyP(5+) reduces hyaluronand egradation-induced inflammation in mouse articularchondrocytes stimulated with Fe (II) plus ascorbate," International Journal of Biochemistry and Cell Biology, vol. 45, no. 8, pp. 1610-1619, 2013.
36. I. Juranek, R. Stern, and L. Šoltes, "Hyaluronan peroxidation is required for normal synovial function: an hypothesis," Medical Hypotheses, vol. 82, no. 6, pp. 662-666, 2014.
37. D. Manzanares, M.-E. Monzon, R. C. Savani, and M. Salathe, "Apical oxidative hyaluronan degradation stimulates airway ciliary beating via RHAMM and RON," The American Journal of Respiratory Cell and Molecular Biology, vol. 37, no. 2, pp. 160-168, 2007.
38. S. M. Casalino-Matsuda, M. E. Monzon, G. E. Conner, M. Salathe, and R. M. Forteza, "Role of hyaluronan and reactive oxygen species in tissue kallikrein-mediated epidermal growth factor receptor activation in human airways," Journal of Biological Chemistry, vol. 279, no. 20, pp. 21606-21616, 2004.
39. K. S. Girish and K. Kemparaju, "Themagic glue hyaluronan and itseraser hyaluronidase: a biological overview," Life Sciences, vol. 80, no. 21, pp. 1921-1943, 2007.
40. C. Hardwick, K. Hoare, R. Owens et al., "Molecular cloning of a novel hyaluronan receptor that mediates tumor cell motility," The Journal of Cell Biology, vol. 117, no. 6, pp. 1343-1350, 1992.
41. C. Termeer, F. Benedix, J. Sleeman et al., "Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4," Journal of Experimental Medicine, vol. 195, no. 1, pp. 99-111, 2002.
42. R. M. Forteza, S. M. Casalino-Matsuda, N. S. Falcon, M. V. Gattas, and M. E. Monzon, "Hyaluronan and layilin mediate loss of airway epithelial barrier function induced by cigarette smoke by decreasing," Journal of Biological Chemistry, vol. 287, no. 50, pp. 42288-42298, 2012.
43. P. Bono, K. Rubin, J. M. G. Higgins, and R. O. Hynes, "Layilin, a novel integral membrane protein, is a hyaluronan receptor," Molecular Biology of the Cell, vol. 12, no. 4, pp. 891-900, 2001.
44. C. M. Carreira, S. M. Nasser, E. di Tomaso et al., "LYVE-1 is not restricted to the lymph vessels: expression in normal liver blood sinusoids and down-regulation in human liver cancer and cirrhosis," Cancer Research, vol. 61, no. 22, pp. 8079-8084, 2001.
45. R. Prevo, S. Banerji, D. J. P. Ferguson, S. Clasper, and D. G. Jackson, "Mouse LYVE-1 is an endocytic receptor for hyaluronan in lymphatic endothelium," Journal of Biological Chemistry, vol. 276, no. 22, pp. 19420-19430, 2001.
46. S. Banerji, J. Ni, S.-X. Wang et al., "LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan," The Journal of Cell Biology, vol. 144, no. 4, pp. 789-801, 1999.
47. J. A. Weigel, R. C. Raymond, C. McGary, A. Singh, and P. H. Weigel, "A blocking antibody to the hyaluronan receptor for endocytosis (HARE) inhibits hyaluronan clearance by perfused liver," Journal of Biological Chemistry, vol. 278, no. 11, pp. 9808-9812, 2003.
48. J. A. Weigel, R. C. Raymond, and P. H. Weigel, "The hyaluronan receptor for endocytosis (HARE) is notCD44 orCD54 (ICAM-1)," Biochemical and Biophysical Research Communications, vol. 294, no. 4, pp. 918-922, 2002.
49. B. Zhou, J. A. Weigel, L. Fauss, and P. H. Weigel, "Identification of the hyaluronan receptor for endocytosis (HARE)," Journal of Biological Chemistry, vol. 275, no. 48, pp. 37733-37741, 2000.
50. B. P. Toole, S. Ghatak, and S. Misra, "Hyaluronan oligosaccharides as a potential anticancer therapeutic," Current Pharmaceutical Biotechnology, vol. 9, no. 4, pp. 249-252, 2008.
51. C. Yang, M. Cao, H. Liu et al., "The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering," The Journal of Biological Chemistry, vol. 287, no. 51, pp. 43094-43107, 2012.
52. P. M. Wolny, S. Banerji, C. Gounou et al., "Analysis of CD44-hyaluronan interactions in an artificial membrane system: insights into the distinct binding properties of high and low molecular weight hyaluronan," Journal of Biological Chemistry, vol. 285, no. 39, pp. 30170-30180, 2010.
53. K. R. Taylor, K. Yamasaki, K. A. Radek et al., "Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on toll-like receptor 4, CD44, and MD-2," The Journal of Biological Chemistry, vol. 282, no. 25, pp. 18265-18275, 2007.
54. S. Garantziotis, Z. Li, E. N. Potts et al., "Hyaluronan mediates ozone-induced airway hyperresponsiveness in mice," The Journal of Biological Chemistry, vol. 284, no. 17, pp. 11309-11317, 2009.
55. S. Garantziotis, Z. Li, E. N. Potts et al., "TLR4 is necessary for hyaluronan-mediated airway hyperresponsiveness after ozone inhalation," The American Journal of Respiratory and Critical Care Medicine, vol. 181, no. 7, pp. 666-675, 2010.
56. J. D. Powell and M. R. Horton, "Threat matrix: low-molecularweight hyaluronan (HA) as a danger signal," Immunologic Research, vol. 31, no. 3, pp. 207-218, 2005.
57. G. M. Campo, A. Avenoso, S. Campo, A. DAscola, G. Nastasi, and A. Calatroni, "Small hyaluronan oligosaccharides induce inflammation by engaging both toll-like-4 and CD44 receptors in human chondrocytes," Biochemical Pharmacology, vol. 80, no. 4, pp. 480-490, 2010.
58. K. R. Taylor, J. M. Trowbridge, J. A. Rudisill, C. C. Termeer, J. C. Simon, and R. L. Gallo, "Hyaluronan fragments stimulate endothelial recognition of injury through TLR4," The Journal of Biological Chemistry, vol. 279, no. 17, pp. 17079-17084, 2004.
59. C. C. Termeer, J. Hennies, U. Voith et al., "Oligosaccharides of hyaluronan are potent activators of dendritic cells," Journal of Immunology, vol. 165, no. 4, pp. 1863-1870, 2000.
60. R. Schmits, J. Filmus, N. Gerwin et al., "CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity," Blood, vol. 90, no. 6, pp. 2217-2233, 1997.
61. V. A. Higman, D. C. Briggs, D. J. Mahoney et al., "A refined model for the TSG-6 link module in complex with hyaluronan: use of defined oligosaccharides to probe structure and function," Journal of Biological Chemistry, vol. 289, no. 9, pp. 5619-5634, 2014.
62. M. E. Lauer, T. T. Glant, K. Mikecz et al., "Irreversible heavy chain transfer to hyaluronan oligosaccharides by tumor necrosis factor-stimulated gene-6," The Journal of Biological Chemistry, vol. 288, no. 1, pp. 205-214, 2013.
63. K. A. Scheibner, M. A. Lutz, S. Boodoo, M. J. Fenton, J. D. Powell, and M. R. Horton, "Hyaluronan fragments act as an endogenous danger signal by engaging TLR2," Journal of Immunology, vol. 177, no. 2, pp. 1272-1281, 2006.
64. G. M. Campo, A. Avenoso, S. Campo, A. DAscola, P. Traina, and A. Calatroni, "Differential effect ofmolecular size HA in mouse chondrocytes stimulated with PMA," Biochimica et Biophysica Acta-General Subjects, vol. 1790, no. 10, pp. 1353-1367, 2009.
65. G. M. Campo, A. Avenoso, A. DAscola et al., "Hyaluronan differently modulates TLR-4 and the inflammatory response in mouse chondrocytes," BioFactors, vol. 38, no. 1, pp. 69-76, 2012.
66. G. M. Campo, A. Avenoso, A. DAscola et al., "4-mer hyaluronan oligosaccharides stimulate inflammation response in synovial fibroblasts in part via TAK-1 and in part via p38-MAPK," Current Medicinal Chemistry, vol. 20, no. 9, pp. 1162-1172, 2013.
67. F. Gao, C. X. Yang, W. Mo, Y. W. Liu, and Y. Q. He, "Hyaluronan oligosaccharides are potential stimulators to angiogenesis via RHAMM mediated signal pathway in wound healing," Clinical and Investigative Medicine, vol. 31, no. 3, pp. E106-E116, 2008.
68. S. P. Evanko, T. Parks, and T. N. Wight, "Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle," Journal of Histochemistry and Cytochemistry, vol. 52, no. 12, pp. 1525-1535, 2004.
69. S. P. Evanko and T. N. Wight, "Intracellular localization of hyaluronan in proliferating cells," Journal of Histochemistry and Cytochemistry, vol. 47, no. 10, pp. 1331-1342, 1999.
70. S. Adamia, J. Kriangkum, A. R. Belch, and L. M. Pilarski, "Aberrant posttranscriptional processing of hyaluronan synthase 1 in malignant transformation and tumor progression," in Advances in Cancer Research, vol. 123, pp. 67-94, Elsevier, New York, NY, USA, 2014.
71. V. C.Hascall, A. K.Majors, C. A. de laMotte et al., Intracellular hyaluronan: a new frontier for inflammation? Biochimica et Biophysica Acta, vol. 1673, no. 1-2, pp. 312, 2004.
72. R. Stern, "Hyaluronidases in cancer biology," Seminars in Cancer Biology, vol. 18, no. 4, pp. 275-280, 2008.
73. G. M. Campo, A. Avenoso, A. DAscola et al., "The inhibition of hyaluronan degradation reduced pro-inflammatory cytokines in mouse synovial fibroblasts subjected to collagen-induced arthritis," Journal of Cellular Biochemistry, vol. 113, no. 6, pp. 1852-1867, 2012.
74. E. N. Harris, S. V. Kyosseva, J. A. Weigel, and P. H. Weigel, "Expression, processing, and glycosaminoglycan binding activity of the recombinant human 315-kDa hyaluronic acid receptor for endocytosis (HARE)," The Journal of Biological Chemistry, vol. 282, no. 5, pp. 2785-2797, 2007.
75. Q. Hua, C. B. Knudson, and W. Knudson, "Internalization of hyaluronan by chondrocytes occurs via receptor-mediated endocytosis," Journal of Cell Science, vol. 106, part 1, pp. 365-375, 1993.
76. H. J. Greyner, T. Wiraszka, L.-S. Zhang, W. M. Petroll, and M. E. Mummert, "Inducible macropinocytosis of hyaluronan in B16-F10 melanoma cells," Matrix Biology, vol. 29, no. 6, pp. 503-510, 2010.
77. L. Rodén, P. Campbell, J. R. Fraser, T. C. Laurent, H. Pertoft, and J. N. Thompson, "Enzymic pathways of hyaluronan catabolism. ," Ciba Foundation symposium, vol. 143, pp. 60-76, 1989.
78. L. Gushulak, R. Hemming, D. Martin, V. Seyrantepe, A. Pshezhetsky, and B. Triggs-Raine, "Hyaluronidase 1 and β-hexosaminidase have redundant functions in hyaluronan and chondroitin sulfate degradation," The Journal of Biological Chemistry, vol. 287, no. 20, pp. 16689-16697, 2012.
79. Y.-Y. Liu, C.-H. Lee, R. Dedaj et al., "High-molecular-weight hyaluronan-a possible new treatment for sepsis-induced lung injury: a preclinical study in mechanically ventilated rats," Critical Care, vol. 12, no. 4, article R102, 2008.
80. Z. Li, E. N. Potts-Kant, S. Garantziotis, W. M. Foster, and J. W. Hollingsworth, "Hyaluronan signaling during ozone-induced lung injury requires TLR4, MyD88, and TIRAP," PLoSONE, vol. 6, no. 11, Article ID e27137, 2011.
81. F. Feng, Z. Li, E. N. Potts-Kant et al., "Hyaluronan activation of theNlrp3 inflammasome contributes to the development of airway hyperresponsiveness," Environmental Health Perspectives, vol. 120, no. 12, pp. 1692-1698, 2012.
82. A. Varricchio, M. Capasso, F. Avvisati et al., "Inhaledhyaluronic acid as ancillary treatment in children with bacterial acute rhinopharyngitis," Journal of Biological Regulators and Homeostatic Agents, vol. 28, no. 3, pp. 537-43, 2014.
83. M. Ros, R. Casciaro, F. Lucca et al., "Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, rand omized, controlled clinical trial," Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 27, no. 2, pp. 133-137, 2014.
84. F. Cresta, A. Naselli, F. Favilli, and R. Casciaro, "Inhaled hypertonic saline+hyaluronic acid in cystic fibrosis with asthma-like symptoms: a new therapeutic chance," BMJ Case Reports, vol. 2013, 2013.
85. M. L. Furnari, L. Termini, G. Traverso et al., "Nebulized hypertonic saline containing hyaluronic acid improves tolerability in patients with cystic fibrosis and lung disease compared with nebulized hypertonic saline alone: a prospective, rand omized, double-blind, controlled study," Therapeutic Advances in Respiratory Disease, vol. 6, no. 6, pp. 315-322, 2012.
86. M. R. Horton, C. M. McKee, C. Bao et al., "Hyaluronan fragments synergize with interferon-γ to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages," The Journal of Biological Chemistry, vol. 273, no. 52, pp. 35088-35094, 1998.
87. F. E. Lennon and P. A. Singleton, "Role of hyaluronan and hyaluronan-binding proteins in lung pathobiology," The American Journal of Physiology-Lung Cellular and Molecular Physiology, vol. 301, no. 2, pp. L137-L147, 2011.
88. A. R. Poole, J. Witter, N. Roberts et al., "Inflammation and cartilage metabolism in rheumatoid arthritis: studies of the blood markers hyaluronic acid, orosomucoid, and keratan sulfate," Arthritis and Rheumatism, vol. 33, no. 6, pp. 790-799, 1990.
89. B. P. Toole, A. Zoltan-Jones, S. Misra, and S. Ghatak, "Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions," Cells Tissues Organs, vol. 179, no. 1-2, pp. 66-72, 2005.
90. M. Y. Kim, J. Muto, and R. L. Gallo, "Hyaluronic acid oligosaccharides suppress TLR3-dependent cytokine expression in a TLR4-dependent manner," PLoS ONE, vol. 8, no. 8, Article ID e72421, 2013.
91. C. W. Winkler, S. C. Foster, A. Itakura et al., "Hyaluronan oligosaccharides perturb lymphocyte slow rolling on brain vascular endothelial cells: implications for inflammatory demyelinating disease," Matrix Biology, vol. 32, no. 3-4, pp. 160-168, 2013.
92. S. Ghatak, S. Misra, and B. P. Toole, "Hyaluronan constitutively regulates ErbB2 phosphorylation and signaling complex formation in carcinoma cells," TheJournal of Biological Chemistry, vol. 280, no. 10, pp. 8875-8883, 2005.
93. S. Misra, B. P. Toole, and S. Ghatak, "Hyaluronan constitutively regulates activation of multiple receptor tyrosine kinases in epithelial and carcinoma cells," The Journal of Biological Chemistry, vol. 281, no. 46, pp. 34936-34941, 2006.